NM_006817.4:c.58G>A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_006817.4(ERP29):​c.58G>A​(p.Gly20Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

ERP29
NM_006817.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.513

Publications

0 publications found
Variant links:
Genes affected
ERP29 (HGNC:13799): (endoplasmic reticulum protein 29) This gene encodes a protein which localizes to the lumen of the endoplasmic reticulum (ER). It is a member of the protein disulfide isomerase (PDI) protein family but lacks an active thioredoxin motif, suggesting that this protein does not function as a disulfide isomerase. The canonical protein dimerizes and is thought to play a role in the processing of secretory proteins within the ER. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2016]
TMEM116 (HGNC:25084): (transmembrane protein 116) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12751055).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERP29NM_006817.4 linkc.58G>A p.Gly20Ser missense_variant Exon 1 of 3 ENST00000261735.4 NP_006808.1 P30040-1V9HW71
ERP29NM_001034025.2 linkc.58G>A p.Gly20Ser missense_variant Exon 1 of 2 NP_001029197.1 P30040-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERP29ENST00000261735.4 linkc.58G>A p.Gly20Ser missense_variant Exon 1 of 3 1 NM_006817.4 ENSP00000261735.3 P30040-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.85e-7
AC:
1
AN:
1460356
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
726520
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33344
American (AMR)
AF:
0.00
AC:
0
AN:
44542
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26080
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39326
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86182
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53360
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
9.00e-7
AC:
1
AN:
1111426
Other (OTH)
AF:
0.00
AC:
0
AN:
60332
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 08, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.58G>A (p.G20S) alteration is located in exon 1 (coding exon 1) of the ERP29 gene. This alteration results from a G to A substitution at nucleotide position 58, causing the glycine (G) at amino acid position 20 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.067
T;.
Eigen
Benign
-0.63
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.76
D
LIST_S2
Benign
0.70
T;T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.13
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.90
L;L
PhyloP100
0.51
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
0.24
N;D
REVEL
Benign
0.033
Sift
Benign
0.41
T;T
Sift4G
Benign
0.11
T;D
Polyphen
0.0010
B;.
Vest4
0.22
MutPred
0.52
Gain of catalytic residue at G20 (P = 0.1128);Gain of catalytic residue at G20 (P = 0.1128);
MVP
0.14
MPC
0.19
ClinPred
0.073
T
GERP RS
1.4
PromoterAI
0.016
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3
Varity_R
0.046
gMVP
0.49
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr12-112451327; API